Glenmark Pharmaceuticals
GLENMARK.NS
#2770
Rank
A$7.47 B
Marketcap
$26.50
Share price
-0.50%
Change (1 day)
86.30%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): $0.17

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.17. In 2022 the company made an earnings per share (EPS) of $0.60 a decrease over its 2021 EPS that were of $0.75.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.17-71.87%
2022$0.60-20.18%
2021$0.757.13%
2020$0.7025.72%
2019$0.56-22.01%
2018$0.7130.15%
2017$0.55-34.82%
2016$0.8463.09%
2015$0.519.68%
2014$0.47-26.58%
2013$0.640.51%
2012$0.64